Eli Lilly & Co. (LLY) will begin studies to see if its blockbuster weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said. These medicines can be useful for other things we don't think about connected to weight," Ricks said during an interview with David Rubenstein at a meeting of the Economics Club in Washington, DC.

Bloomberg videos, provided by MT Newswires